MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes

Abstract

Hyperglycemia is an important initiator of cardiovascular disease, contributing to the development of cardiomyocyte death and diabetic complications. The purpose of the present study was to investigate whether high glucose state could induce apoptosis of rat cardiomyocyte cell line H9c2 through microRNA-mediated Bcl-2 signaling pathway. The expression of miR-34a and Bcl-2 mRNA was detected by using real-time PCR. Western blotting was used to examine the changes in apoptosis-associated protein Bcl-2. Apoptosis of H9c2 cells was tested by using flow cytometry. The results showed that the expression of miR-34a was significantly elevated and that of Bcl-2 was strongly reduced, and apoptosis of cardiomyocytes was apparently increased in the high-glucose-treated H9c2 cells as compared with normal-glucose-treated controls. In addition, we identified Bcl-2 gene was the target of miR-34a. miR-34a mimics reduced the expression of Bcl-2 and increased glucose-induced apoptosis, but miR-34a inhibitor acted as the opposite mediator. Our data demonstrate that miR-34a contributes to high glucose-induced decreases in Bcl-2 expression and subsequent cardiomyocyte apoptosis.

Keywords

high glucose / Bcl-2 / apoptosis / miR-34a

References

[1] RublerS, DlugashJ, YuceogluYZ, et al.. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol, 1972, 30(6): 595-602

[2] FeinFS. Diabetic cardiomyopathy. Diabetes Care, 1990, 13(11): 1169-1179

[3] ReganTJ, AhmedS, HaiderB, et al.. Diabetic cardiomyopathy: experimental and clinical observations. N J Med, 1994, 91(11): 776-778

[4] AsbunJ, VillarrealFJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol, 2006, 47(4): 693-700

[5] RotaM, LeCapitaineN, HosodaT, et al.. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res, 2006, 99(1): 42-52

[6] YoonYS, UchidaS, MasuoO, et al.. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation, 2005, 111(6): 2073-2085

[7] BartelDP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2): 281-297

[8] RooijEV, SutherlandL, QiX, et al.. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 2007, 316(5824): 575-579

[9] MirandaKC, HuynhT, TayY, et al.. A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell, 2006, 126(6): 1203-1217

[10] RooijEV, SutherlandLB, LiuN, et al.. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA, 2006, 103(48): 18 255-18 260

[11] McKinseyTA, OlsonEN. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest, 2005, 115(3): 538-546

[12] RooijEV, OlsonEN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest, 2007, 117(9): 2369-2376

[13] KongL, ZhuJ, HanW, et al.. Significance of serum mi croRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol, 2011, 48(1): 61-69

[14] BertoniAG, HundleyWG, MassingMW, et al.. Heart failure prevalence, incidence, and mortality in the elderly with diabetess. Diabetes Care, 2004, 27: 699-703

[15] RogerVL, GoAS, Lloyd-JonesDM, et al.. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation, 2012, 125(1): e2-220

[16] He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature, 200,447(7148):1130–1134

[17] DostieJ, MourelatosZ, YangM, et al.. Numerous microRNPs in neuronal cells containing novel microRNAs. RNA, 2003, 9(2): 180-186

[18] Lagos-QuintanaM, RauhutR, YalcinA, et al.. Identification of tissue-specific microRNAs from mouse. Curr Biol, 2002, 12(9): 9

[19] ItoT, YagiS, YamakuchiM. MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun, 2010, 398(4): 735-740

[20] ErmekingH. The miR-34 family in cancer and apoptosis. Cell Death Differ, 2010, 17(2): 193-199

[21] ColeKA, AttiyehEF, MosseYP, et al.. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res, 2008, 6(5): 735-742

[22] LovisP, RoggliE, LaybuttDR, et al.. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes, 2008, 57(10): 2728-2736

[23] BaekD, VillénJ, ShinC, et al.. The impact of microRNAs on protein output. Nature, 2008, 455(7209): 64-71

[24] WilliamsAH, LiuN, VanER, et al.. MicroRNA control of muscle development and disease. Curr Opin Cell Biol, 2009, 21(3): 461-469

[25] CimminoA, CalinGA, FabbriM, et al.. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA, 2005, 102(39): 13 944-13 949

[26] KatareR, CaporaliA, ZentilinL, et al.. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res, 2011, 108(10): 1238-1251

[27] ReedJC, MeisterL, TanakaS, et al.. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res, 1991, 51(24): 6529-6538

[28] BommerGT, GerinI, FengY, et al.. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol, 2007, 17(15): 1298-1307

[29] ChangTC, WentzelEA, KentOA, et al.. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cel, 2007, 26(5): 745-752

[30] YamakuchiM, LowensteinCJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle, 2009, 8(5): 712-715

[31] WelchC, ChenY, StallingsRL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene, 2007, 26(34): 5017-5022